Patient in France critical after reinfection with coronavirus variant discovered in SA - study

0:00
play article
Subscribers can listen to this article
A health worker in safety gear.
A health worker in safety gear.
Oliver Berg/picture alliance via Getty Images
  • Months after recovering from Covid-19, a 58-year-old man in France has been infected with the coronavirus variant first discovered in South Africa.
  • The man tested negative for Covid-19 twice in December 2020, however, he was admitted in hospital and diagnosed with the 501Y.V2 variant.
  • He is currently in a critical condition on a ventilator.

Doctors in France are treating a critically ill patient infected with the 501Y.V2 coronavirus variant - first discovered in South Africa -  four months after he recovered from Covid-19, in what study authors said was the first case of its kind.

The 58-year-old man had a history of asthma and initially tested positive for Covid-19 in September when he presented to medical staff with a fever and shortness of breath.

The symptoms persisted only for a few days, and the man tested negative for Covid-19 twice in December 2020.

However, he was admitted to hospital in January and diagnosed with the South African variant.

The patient's condition worsened, and he is currently in a "critical condition" on a ventilator.

"This is, to our knowledge, the first description of reinfection with the South African [501Y.V2 coronavirus variant] causing severe Covid-19, four months after a first mild infection," said authors of a study published this week in the journal Clinical Infectious Diseases.

The 501Y.V2 coronavirus variant emerged late last year in South Africa and immediately provoked alarm among disease specialists.

It has eight key mutations, one of which affects the virus' spike protein, making it more effective at binding to human cells and therefore more infectious.

Vaccine manufacturers Pfizer/BioNTech and Moderna say their mRNA vaccines retain their effectiveness against the 501Y.V2 coronavirus variant and another variants that emerged last year in Britain.

However, a study last week showed that AstraZeneca's vaccine failed to prevent mild and moderate cases of infection of the 501Y.V2 coronavirus variant found in South Africa.

"The impact of 501Y.V2 mutations on the effectiveness of vaccines developed based on earlier SARS-CoV-2 strains is still unknown," said the authors of the reinfection study.


Did you know you can comment on this article? Subscribe to News24 and add your voice to the conversation.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24
Lockdown For
DAYS
HRS
MINS
Voting Booth
When a Covid-19 vaccine for under 16's becomes available, will you be taking your children to get it?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes, immediately!
38% - 2946 votes
I'll wait to see how others respond
26% - 2035 votes
No, I don't think they need it
36% - 2861 votes
Vote
ZAR/USD
14.98
(+0.29)
ZAR/GBP
20.86
(+0.69)
ZAR/EUR
18.05
(+0.69)
ZAR/AUD
11.64
(+0.09)
ZAR/JPY
0.14
(+0.60)
Gold
1723.82
(-0.84)
Silver
26.49
(-0.99)
Platinum
1184.00
(-0.96)
Brent Crude
64.90
(0.00)
Palladium
2349.99
(+0.85)
All Share
67536.96
(+2.12)
Top 40
62107.04
(+2.23)
Financial 15
12456.31
(+2.10)
Industrial 25
88082.08
(+2.25)
Resource 10
68969.71
(+2.24)
All JSE data delayed by at least 15 minutes morningstar logo